Abstract B134: The p38MAPK inhibitor LY2228820 dimesylate, in combination with cytotoxic agents, displays strong antitumor activity in human glioblastoma, multiple myeloma, and other mouse xenograft models.

Susan E. Pratt, Louis F. Stancato, Raymond Gilmour et al.|Molecular Cancer Therapeutics|2011

Cited by 0